17 research outputs found
Medical use of cannabis and cannabinoids containing products – Regulations in Europe and North America
An international comparison of THA patients, implants, techniques, and survivorship in Sweden, Australia, and the United States
Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States
ObjectiveTo determine the extent to which states and localities include dementia as a qualifying condition for medical marijuana and how common this indication is.MethodsThe authors reviewed authorizing legislation and medical marijuana program websites and annual reports for the states and localities where medical marijuana is legal.ResultsOf the 24 states and localities where medical marijuana is legal, dementia is a qualifying condition in 10 (41.7%), primarily for agitation of Alzheimer disease. In the five states where information was available regarding qualifying conditions for certification, dementia was the indication for <0.5% of medical marijuana certifications.ConclusionDementia is somewhat commonly listed as a potential qualifying condition for medical marijuana. Currently, few applicants for medical marijuana list dementia as the reason for seeking certification. However, given increasingly open attitudes toward recreational and medical marijuana use, providers should be aware that dementia is a potential indication for licensing, despite lack of evidence for its efficacy